How should I manage an 18-year-old hypertensive patient with occasional palpitations, elevated renin, normal aldosterone, normal CT aortogram and CECT, normal plasma metanephrines, and no renal artery stenosis who is already taking amlodipine 5 mg daily?

Management of Young Hypertensive with Elevated Renin and Normal Aldosterone

This 18-year-old patient with elevated renin, suppressed aldosterone, and negative secondary hypertension workup most likely has high-renin essential hypertension and should be escalated to combination therapy with an ACE inhibitor or ARB plus amlodipine, targeting blood pressure 120-129 mmHg systolic. 1

Diagnostic Interpretation

Your patient's biochemical profile—elevated renin with normal aldosterone—effectively rules out the most common secondary causes you've already appropriately investigated:

• Primary aldosteronism excluded: Normal aldosterone with elevated renin gives a low aldosterone-to-renin ratio, opposite of what you'd see in primary aldosteronism 2, 3
• Pheochromocytoma excluded: Normal plasma metanephrines
• Renovascular disease excluded: No renal artery stenosis on imaging
• Coarctation excluded: Normal CT aortogram

Important caveat: Amlodipine can artificially elevate renin levels by 17% on average 4, but this modest effect doesn't explain markedly elevated renin in your patient. The elevated renin likely represents true high-renin essential hypertension, which occurs in 15-20% of hypertensive patients 5.

Why This Matters Clinically

High-renin essential hypertension in young patients suggests renin-angiotensin system-driven hypertension 5. These patients have enhanced vascular reactivity to angiotensin II and respond particularly well to RAS blockade. The palpitations may reflect heightened sympathetic tone often accompanying high-renin states.

Treatment Algorithm

Step 1: Escalate to Dual Combination Therapy (NOW)

Add an ACE inhibitor or ARB to the current amlodipine 5 mg daily 1:

• Preferred combinations per 2024 ESC guidelines: RAS blocker + CCB (which you'll achieve) 1
• Consider: Lisinopril 10-20 mg daily OR Losartan 50-100 mg daily
• Continue amlodipine 5 mg (can increase to 10 mg if needed) 6

Rationale: At age 18 with confirmed hypertension, comprehensive screening for secondary causes is recommended 1, which you've completed. The 2024 ESC guidelines explicitly recommend combination therapy as initial treatment for most patients with confirmed hypertension (BP ≥140/90 mmHg) 1. Monotherapy with amlodipine 5 mg is inadequate.

Step 2: Target Blood Pressure

Aim for systolic BP 120-129 mmHg 1:

• This target reduces cardiovascular risk in young patients
• Reassess every 1-3 months until controlled 1
• Control should be achieved within 3 months 1

Step 3: If Dual Therapy Fails

Escalate to triple therapy: RAS blocker + amlodipine + thiazide-like diuretic (chlorthalidone 12.5-25 mg or indapamide 1.25-2.5 mg) 7, 1

Step 4: If Triple Therapy Fails (Resistant Hypertension)

Add spironolactone 25-50 mg daily 7, 1:

• Most effective fourth agent for resistant hypertension
• Monitor potassium and renal function
• Alternative if not tolerated: eplerenone, amiloride, or bisoprolol 1

Addressing the Palpitations

The palpitations warrant specific attention:

• Likely related to high-renin state: Enhanced sympathetic activity
• Should improve with RAS blockade: ACE inhibitors/ARBs reduce sympathetic outflow
• If persistent after BP control: Consider adding low-dose beta-blocker (though not first-line for hypertension alone in young patients) 1
• Red flag to exclude: If palpitations worsen or new symptoms develop, reconsider pheochromocytoma despite normal metanephrines (rare false negatives exist) 8

Critical Pitfalls to Avoid

1. Don't continue monotherapy: Young patients with hypertension need aggressive treatment to prevent long-term organ damage 1

2. Don't ignore medication effects on renin: While amlodipine raises renin modestly 9, 4, this doesn't invalidate your workup—just be aware when interpreting future aldosterone-to-renin ratios

3. Don't assume "essential hypertension" means benign: High-renin essential hypertension carries enhanced cardiovascular risk and requires optimal control 5

4. Don't forget lifestyle modification: Emphasize sodium restriction (<2 g/day), regular exercise, weight management, and alcohol avoidance alongside medications 1

5. Monitor for evolving secondary causes: A case report documented an 18-year-old who initially tested negative for primary aldosteronism but developed it over 7 years 10. Consider retesting if BP becomes increasingly difficult to control.

Follow-up Strategy

• Recheck BP in 2-4 weeks after starting RAS blocker
• Monitor electrolytes and creatinine 1-2 weeks after starting ACE inhibitor/ARB
• Reassess palpitations at each visit
• Consider ambulatory BP monitoring to confirm control once target achieved
• Lifelong treatment anticipated 1, but emphasize that excellent BP control now prevents stroke, heart attack, and kidney disease later

1